Biodel nets $80.2mm in IPO
Macromolecule drug delivery firm Biodel has netted $80.2mm (including the overallotment) through its initial public offering of 5.75mm shares priced at $15 each, the midpoint of its anticipated range, selling 750k more shares than it had originally planned.
- Drug Delivery
- Large Molecule
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com